ArticleJournal of urban health : bulletin of the New York Academy of Medicine2021
The Sexual and Reproductive Health Burden Index: Development, Validity, and Community-Level Analyses of a Composite Spatial Measure.
Article in Journal of urban health : bulletin of the New York Academy of Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
- Development and validation of a community risk score for sexual and reproductive health in the United States.Health affairs scholar · 2024Article
- Geospatial Social Determinants of Health Correlate with Disparities in Syphilis and Congenital Syphilis Cases in California.Pathogens (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Sexual and Reproductive Health Burden Index (SRHBI) was developed to provide a composite spatial measure of sexual and reproductive health (SRH) indicators that can be widely adopted by urban public health departments for the planning of SRH services. The index was constructed using eight indicators: teen births, low birthweight, infant mortality, new HIV diagnoses, people living with HIV, and incidences of gonorrhea, chlamydia, and syphilis. Chicago Department of Public Health data (2014-2017) were used to calculate index scores for Chicago community areas; scores were mapped to provide geovisualization and global Moran's I was calculated to assess spatial autocorrelation. Cronbach's alpha was calculated to assess internal reliability of the SRHBI. Pearson correlations were conducted to assess concurrent validity and correlation with community-level factors. Linear regression was conducted to assess community-level predictors of the SRHBI. Application of the SRHBI in Chicago demonstrates substantial variation in SRH burden across Chicago's urban landscape with significant spatial autocorrelation of scores (I = .580, p = .001). Internal reliability of the measure was excellent with α = .937. The SRHBI was significantly correlated with other indicators of SRH including rate of prenatal care initiation in the first trimester, rate of preterm births, reported sexual assault incidence, cervical cancer incidence, prostate cancer incidence, and rate of smoking during pregnancy. This suggests good concurrent validity of the measure. Linear regression revealed that the percent of Black residents, percent of household couples that are same-sex, community violence, economic hardship, and population density were significant predictors of the SRHBI. The SRHBI provides a valid, useful, and replicable measure to assess and communicate community-level SRH burden in urban environments. The SRHBI may be scaled through a multi-city public data dashboard and utilized by urban public health departments to optimally target and tailor SRH interventions to communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.